Inactive Instrument

Highlights Zymergen Inc.

Equities

ZY

US98985X1000

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

Zymergen Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	23-01-27	CI
Ginkgo Bioworks Holdings Closes Zymergen Acquisition	22-10-19	MT
Ginkgo Bioworks Holdings, Inc. completed the acquisition of Zymergen Inc. (NasdaqGS:ZY) from a group of shareholders.	22-10-18	CI
Zymergen Says It Cut 80 More Jobs; Co-Founder Zach Serber Stepping Down as Chief Science Officer	22-08-25	MT
ZYMERGEN INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-08-15	AQ
Zymergen Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
North American Morning Briefing : Growth Stocks -2-	22-07-27	DJ
Ginkgo Bioworks to Acquire Zymergen in $300 Million All-Stock Deal; Buys Bayer's Biologics R&D Center for $83 Million	22-07-25	MT
Ginkgo Bioworks to Acquire Zymergen in $300 Million All-Stock Deal; Buys Bayer's Biologics R&D Center for $83 Million	22-07-25	MT
Ginkgo Bioworks Holdings, Inc. entered into a definitive agreement to acquire Zymergen Inc. (NasdaqGS:ZY) from a group of shareholders for approximately $300 million.	22-07-24	CI
Zymergen Sells Six Reconfigurable Automation Carts to Drug Maker Octant	22-07-14	MT
Zymergen Expands Agreement with Octant to Scale Next-Generation Drug Discovery Platform	22-07-14	CI
Zymergen to Provide Zymergen Z2 Polyimide Powder to 3D4Makers	22-06-28	MT
Zymergen Announces R&D Supply Agreement with 3D4Makers to Provide New Polyimide for Use in High-Performance 3D Printing Applications	22-06-28	CI
Zymergen Agrees to Sell Modular Automation System to Octant	22-05-27	MT
Zymergen Inc. Sells Modular Automation System to Octant to Scale Next-Generation Drug Discovery Platform	22-05-26	CI
ZYMERGEN INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-05-12	AQ
Earnings Flash (ZY) ZYMERGEN Reports Q1 Revenue $4.8M, vs. Street Est of $3.34M	22-05-12	MT
Zymergen Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-12	CI
ZYMERGEN INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-K)	22-03-30	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Zymergen Inc.

Equities

ZY

US98985X1000

Highlights

Filters